269 related articles for article (PubMed ID: 22875474)
1. NSAID enteropathy: could probiotics prevent it?
Montalto M; Gallo A; Gasbarrini A; Landolfi R
J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota in NSAID Enteropathy: New Insights From Inside.
Wang X; Tang Q; Hou H; Zhang W; Li M; Chen D; Gu Y; Wang B; Hou J; Liu Y; Cao H
Front Cell Infect Microbiol; 2021; 11():679396. PubMed ID: 34295835
[TBL] [Abstract][Full Text] [Related]
3. [NSAID enteropathy].
Kareva EN
Ter Arkh; 2020 Apr; 92(2):85-92. PubMed ID: 32598724
[TBL] [Abstract][Full Text] [Related]
4. NSAID enteropathy and bacteria: a complicated relationship.
Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
Simon O'Brien E; Robert A; Gauthier D; Le Cavorzin A; Planchais J; Roux X; Verleye M; Castagné V
Benef Microbes; 2023 Sep; 14(3):239-253. PubMed ID: 37646075
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.
Park SC; Chun HJ; Kang CD; Sul D
World J Gastroenterol; 2011 Nov; 17(42):4647-53. PubMed ID: 22180706
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.
Guslandi M
World J Gastroenterol; 2012 Aug; 18(31):4241-2. PubMed ID: 22919262
[TBL] [Abstract][Full Text] [Related]
8. Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics.
Rekatsina M; Paladini A; Cifone MG; Lombardi F; Pergolizzi JV; Varrassi G
Adv Ther; 2020 May; 37(5):1933-1945. PubMed ID: 32291647
[TBL] [Abstract][Full Text] [Related]
9. Review article: a practical approach to the clinical management of NSAID enteropathy.
Srinivasan A; De Cruz P
Scand J Gastroenterol; 2017 Sep; 52(9):941-947. PubMed ID: 28587496
[TBL] [Abstract][Full Text] [Related]
10. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study.
Montalto M; Gallo A; Curigliano V; D'Onofrio F; Santoro L; Covino M; Dalvai S; Gasbarrini A; Gasbarrini G
Aliment Pharmacol Ther; 2010 Jul; 32(2):209-14. PubMed ID: 20384610
[TBL] [Abstract][Full Text] [Related]
12. NSAIDs and the small bowel.
Tai FWD; McAlindon ME
Curr Opin Gastroenterol; 2018 May; 34(3):175-182. PubMed ID: 29438118
[TBL] [Abstract][Full Text] [Related]
13. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
[TBL] [Abstract][Full Text] [Related]
14. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
Otani K; Tanigawa T; Watanabe T; Shimada S; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
Digestion; 2017; 95(1):22-28. PubMed ID: 28052268
[TBL] [Abstract][Full Text] [Related]
15. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
Adebayo D; Bjarnason I
Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800
[TBL] [Abstract][Full Text] [Related]
16. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies.
Wallace JL
Br J Pharmacol; 2012 Jan; 165(1):67-74. PubMed ID: 21627632
[TBL] [Abstract][Full Text] [Related]
17. Present status and strategy of NSAIDs-induced small bowel injury.
Higuchi K; Umegaki E; Watanabe T; Yoda Y; Morita E; Murano M; Tokioka S; Arakawa T
J Gastroenterol; 2009; 44(9):879-88. PubMed ID: 19568687
[TBL] [Abstract][Full Text] [Related]
18. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
Bjarnason I; Takeuchi K
J Gastroenterol; 2009; 44 Suppl 19():23-9. PubMed ID: 19148789
[TBL] [Abstract][Full Text] [Related]
19. Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents.
Satoh H; Takeuchi K
Curr Med Chem; 2012; 19(1):82-9. PubMed ID: 22300080
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
Wallace JL
World J Gastroenterol; 2013 Mar; 19(12):1861-76. PubMed ID: 23569332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
